Literature DB >> 8454101

Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians.

M Prochazka1, S Lillioja, J F Tait, W C Knowler, D M Mott, M Spraul, P H Bennett, C Bogardus.   

Abstract

Insulin action in vivo varies widely in nondiabetic Pima Indians. Not all of this variance is attributable to individual differences in obesity, physical fitness, sex, or age, and after correcting for these co-variates, measures of insulin action aggregate in families. Insulin action at maximally stimulating insulin concentrations has a trimodal frequency distribution, particularly among obese individuals. This is consistent with the hypothesis that a codominantly inherited autosomal gene, unrelated to obesity, determines MaxM in the population. Preliminary sib-pair linkage analyses indicated the possibility of linkage between MaxM and the GYPA/B locus (encoding the MNSs red cell surface antigens) on chromosome 4q. To confirm and extend these findings, 10 additional loci on 4q were typed in 123 siblings and many of their parents from 46 nuclear families. The results indicate significant (P < 0.001) linkage of the FABP2 and ANX5 loci on 4q with MaxM, and of FABP2 with fasting insulin concentration. No linkage was found between the 4q markers and obesity. Our findings indicate that a gene on 4q, near the FABP2 and ANX5 loci, contributes to in vivo insulin action in Pima Indians.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454101     DOI: 10.2337/diab.42.4.514

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  27 in total

1.  Characterization of Japanese families with early-onset type 2 (non-insulin dependent) diabetes mellitus and screening for mutations in the glucokinase and mitochondrial tRNA(Leu(UUR)) genes.

Authors:  N Iwasaki; H Ohgawara; H Nagahara; M Kawamura; G I Bell; Y Omori
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

2.  A novel (TA)n polymorphism in the hexokinase II gene: application to noninsulin-dependent diabetes mellitus in the Pima Indians.

Authors:  H Ardehali; G E Tiller; R L Printz; H Mochizuki; M Prochazka; D K Granner
Journal:  Hum Genet       Date:  1996-04       Impact factor: 4.132

Review 3.  [1997 diabetes update].

Authors:  A Pfeiffer
Journal:  Med Klin (Munich)       Date:  1997-11-15

Review 4.  Dietary fats and insulin action.

Authors:  L H Storlien; L A Baur; A D Kriketos; D A Pan; G J Cooney; A B Jenkins; G D Calvert; L V Campbell
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

5.  Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians.

Authors:  M Majer; D M Mott; H Mochizuki; J C Rowles; O Pedersen; W C Knowler; C Bogardus; M Prochazka
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 6.  Skeletal muscle membrane lipids and insulin resistance.

Authors:  L H Storlien; D A Pan; A D Kriketos; J O'Connor; I D Caterson; G J Cooney; A B Jenkins; L A Baur
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

7.  Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q.

Authors:  H El-Shanti; A C Lidral; N Jarrah; L Druhan; K Ajlouni
Journal:  Am J Hum Genet       Date:  2000-03-14       Impact factor: 11.025

Review 8.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

9.  Multifactor-dimensionality reduction shows a two-locus interaction associated with Type 2 diabetes mellitus.

Authors:  Y M Cho; M D Ritchie; J H Moore; J Y Park; K-U Lee; H D Shin; H K Lee; K S Park
Journal:  Diabetologia       Date:  2004-01-17       Impact factor: 10.122

10.  Serum leptin concentration is linked to chromosomes 2 and 6 in the OLETF rat, an animal model of type 2 diabetes with mild obesity.

Authors:  Tomoe Ogino; Daniel H Moralejo; Hiroyuki Kose; Takahisa Yamada; Kozo Matsumoto
Journal:  Mamm Genome       Date:  2003-12       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.